Status:
COMPLETED
Tumor Registry of Advanced Renal Cell Carcinoma
Lead Sponsor:
iOMEDICO AG
Collaborating Sponsors:
Arbeitskreis Klinische Studien
Bund der Urologen e.G.
Conditions:
Renal Cell Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this registry is to record information of therapy reality of metastatic or locally advanced Renal Cell Carcinoma by office-based medical oncologists in Germany.
Detailed Description
The RCC Registry is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with mRCC. At inclusion, data in patient characteristics, comorbiditie...
Eligibility Criteria
Inclusion
- Patients with metastatic or locally advanced Renal Cell Carcinoma requiring therapy
- Start of first palliative therapy within 1 year before enrollment of patient to registry; since enrollment of 1000 Patients: start of first palliative therapy within 4 weeks before enrollment
Exclusion
- \-
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2020
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00610012
Start Date
December 1 2007
End Date
May 15 2020
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
iOMEDICO
Freiburg im Breisgau, Germany